Search

Your search keyword '"Shi V"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Shi V" Remove constraint Author: "Shi V" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
22 results on '"Shi V"'

Search Results

1. Angiotensin–neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure

2. Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF Trial

3. Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights from a Combined PARAGON-HF and PARADIGM-HF Analysis

4. Spatial Variability of the ‘Airbnb Effect’: A Spatially Explicit Analysis of Airbnb’s Impact on Housing Prices in Sydney

5. Angiotensin-neprilysin inhibition and renal outcomes in heart failure with preserved ejection fraction

6. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

7. Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study

8. Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study

10. Potential factors influencing repeated SARS outbreaks in China

11. Potential factors influencing repeated SARS outbreaks in China

12. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

13. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure

14. Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF

15. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

16. Geographic variations in the PARADIGM-HF heart failure trial

17. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure

18. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure

19. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

20. Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk Scores

21. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study

22. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study

Catalog

Books, media, physical & digital resources